Natalizumab alters the TCR repertoire after one year of treatment in four MS patients - Archive ouverte HAL Access content directly
Conference Papers Journal of Translational Medicine Year : 2011

Natalizumab alters the TCR repertoire after one year of treatment in four MS patients

(1, 2) , (1) , (1) , (1) , (1) , (1) , (1) , (2) , (1) , (1) , (1, 2)
1
2

Abstract

n.a

Domains

Life Sciences [q-bio] Immunology
Fichier principal
Vignette du fichier
1479-5876-9-S2-P26.pdf (158.34 Ko) Télécharger le fichier
Vignette du fichier
1479-5876-9-S2-P26.xml (4.69 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Ed. BMC  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00643971

Submitted on : Wednesday, November 23, 2011-1:08:13 PM

Last modification on : Wednesday, April 27, 2022-3:50:03 AM

Long-term archiving on: Friday, February 24, 2012-2:28:50 AM

Download

Dates and versions

inserm-00643971 , version 1 (23-11-2011)

Identifiers

  • HAL Id : inserm-00643971 , version 1

Cite

Laure Michel, Marion Salou, Alexandra Garcia, Nicolas Degauque, Anne Salmon, et al.. Natalizumab alters the TCR repertoire after one year of treatment in four MS patients. 6th european workshop on immune-mediated inflammatory diseases, Nice, France. pp.P26. ⟨inserm-00643971⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-NANTES NANTES-UNIVERSITE
46 View
166 Download

Share

Gmail Facebook Twitter LinkedIn More